Phase
Condition
Esophageal Disorders
Gastroesophageal Reflux Disease (Gerd)
Heartburn (Pediatric)
Treatment
N/AClinical Study ID
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants with grade N or M in the modified LA classification system confirmed byendoscopy at initiation of the pre-observation period (VISIT 1).
Participants with repeated acid reflux symptoms (heartburn or regurgitation) for 2days or more in one week in the 3 weeks before initiation of initiation of thepre-observation period (VISIT 1).
Participants with severity* of moderate or higher for acid reflux symptoms (heartburnor regurgitation) in the 3 weeks before initiation of the pre-observation period (VISIT 1)
- Severity: No symptoms, very mild (symptoms present but often forgotten), mild (notso painful), moderate (rather painful), severe (painful) and very severe (painfulenough to affect night time sleep or daily activities)
- Outpatients (hospitalization for testing possible)
Exclusion
Exclusion Criteria:
Participants with an esophagus-related complication [Barrett's esophagus (3 cm ormore, LSBE), eosinophilic esophagitis, esophageal varices, scleroderma, viral orfungal infections, esophageal stenosis, etc.], or a history of radiotherapy orcryotherapy of the esophagus, a caustic or physiochemical trauma (esophagealsclerotherapy, etc.). However, participants with Barrett's esophagus (less than 3 cm,SSBE) or Schatzki's ring (mucosal tissue ring around inferior esophageal sphincter)are allowed to be included.
Participants who have received surgery or treatment affecting gastroesophageal reflux (cardioplasty, dilation of esophageal stenosis [excluding Schatzki's ring], etc.), orwho have a history of surgery of stomach or duodenum (excluding removal of benignpolyp under endoscopy)
Participants who have acute upper gastrointestinal bleeding, gastric ulcers (mucosaldefects associated with white coating) or duodenal ulcers (mucosal defect with whitecoating) within 30 days before initiation of the pre-observation period (VISIT 1)However, participants with gastric or duodenal erosions are allowed to be included.
Participants with acute gastritis or acute exacerbation of chronic gastritis as acomplication
Participants with a previous or current history of the Zollinger-Ellison syndrome orother gastric acid hypersecretion disorders
Participants with a history of chest pain due to heart disease or with chest painssuspected of being caused by heart disease within one year before initiation of thepre-observation period (VISIT 1)
Study Design
Connect with a study center
Nagoya-shi, Aichi
JapanSite Not Available
Abiko-shi, Chiba
JapanSite Not Available
Kashiwa-shi, Chiba
JapanSite Not Available
Noda-shi, Chiba
JapanSite Not Available
Yachiyo-shi, Chiba
JapanSite Not Available
Saijo-shi, Ehime
JapanSite Not Available
Fukuoka-shi, Fukuoka
JapanSite Not Available
Itoshima-shi, Fukuoka
JapanSite Not Available
Kasuya-gun, Fukuoka
JapanSite Not Available
Onga-gun, Fukuoka
JapanSite Not Available
Kouriyama-shi, Fukushima
JapanSite Not Available
Gifu-shi, Gifu
JapanSite Not Available
Takayama-shi, Gifu
JapanSite Not Available
Annaka-shi, Gunma
JapanSite Not Available
Hiroshima-shi, Hiroshima
JapanSite Not Available
Asahikawa-shi, Hokkaido
JapanSite Not Available
Sapporo-shi, Hokkaido
JapanSite Not Available
Amagasaki-shi, Hyogo
JapanSite Not Available
Kobe-shi, Hyogo
JapanSite Not Available
Nishinomiya-shi, Hyogo
JapanSite Not Available
Takarazuka-shi, Hyogo
JapanSite Not Available
Sagamihara-shi, Kanagawa
JapanSite Not Available
Yokohama-shi, Kanagawa
JapanSite Not Available
Kochi-shi, Kochi
JapanSite Not Available
Suzaki-shi, Kochi
JapanSite Not Available
Kumamoto-shi, Kumamoto
JapanSite Not Available
Kyoto-shi, Kyoto
JapanSite Not Available
Sendai-shi, Miyagi
JapanSite Not Available
Nagasaki-shi, Nagasaki
JapanSite Not Available
Oita-shi, Oita
JapanSite Not Available
Okayama-shi, Okayama
JapanSite Not Available
Osaka-shi, Osaka
JapanSite Not Available
Takatsuki-shi, Osaka
JapanSite Not Available
Saga-shi, Saga
JapanSite Not Available
Kumagaya-shi, Saitama
JapanSite Not Available
Saitama-shi, Saitama
JapanSite Not Available
Tokorozawa-shi, Saitama
JapanSite Not Available
Otawara-shi, Tochigi
JapanSite Not Available
Bunkyo-ku, Tokyo
JapanSite Not Available
Chiyoda-ku, Tokyo
JapanSite Not Available
Chuo-ku, Tokyo
JapanSite Not Available
Hachioji-shi, Tokyo
JapanSite Not Available
Kokubunji-shi, Tokyo
JapanSite Not Available
Nakano-ku, Tokyo
JapanSite Not Available
Oota-ku, Tokyo
JapanSite Not Available
Setagaya-ku, Tokyo
JapanSite Not Available
Shibuya-ku, Tokyo
JapanSite Not Available
Shinjuku-ku, Tokyo
JapanSite Not Available
Shimonoseki-shi, Yamaguchi
JapanSite Not Available
Kofu-shi, Yamanashi
JapanSite Not Available
Turu-shi, Yamanashi
JapanSite Not Available
Yamagata-shi, Ymagata
JapanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.